Revenue: The sum of all revenue fields included for a company's operating activities.
Protagonist Therapeutics, Inc. (PTGX) had Revenue of $434.43M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$434.43M |
$275.19M |
|
-- |
|
$434.43M |
|
$181.59M |
|
$252.84M |
|
$26.57M |
|
$279.41M |
|
$279.41M |
|
$275.19M |
|
$275.19M |
|
$275.19M |
|
$275.19M |
|
$252.84M |
|
$246.86M |
|
61.57M |
|
65.08M |
|
$4.47 |
|
$4.23 |
|
| Balance Sheet Financials | |
$591.64M |
|
$3.19M |
|
$153.08M |
|
$744.73M |
|
$47.40M |
|
-- |
|
$22.03M |
|
$69.43M |
|
$675.29M |
|
$675.29M |
|
$675.29M |
|
61.03M |
|
| Cash Flow Statement Financials | |
$184.15M |
|
$-299.48M |
|
$25.85M |
|
$186.95M |
|
$97.47M |
|
$-89.48M |
|
$37.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
58.20% |
|
58.20% |
|
56.82% |
|
64.32% |
|
63.34% |
|
$182.80M |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
-- |
|
2.63 |
|
138.63 |
|
40.75% |
|
40.75% |
|
36.95% |
|
40.75% |
|
$11.06 |
|
$2.81 |
|
$2.83 |
|